AOM Infusion ("AOM"), a leading provider of specialty infusion and pharmacy services for chronic and complex conditions, has ...
ARLINGTON, Texas, November 26, 2024--(BUSINESS WIRE)--AOM Infusion, a leading provider of specialty infusion therapy, announced today that it has been selected by GC Biopharma as a limited ...
BERWYN, Pa.--(BUSINESS WIRE)--AscellaHealth, a national specialty pharmacy benefit manager (SPBM TM) serving commercial, Medicare and Medicaid segments, announces the launch of its Intravenous ...
CERRITOS, Calif.--(BUSINESS WIRE)--KabaFusion, a leading provider of specialty acute and chronic home infusion therapies, today announced it has acquired the home infusion assets of Lincare, a ...
New information about how to monitor medications given at home has been provided by the results of new research. Many autoimmune neuromuscular disorders, such as Myasthenia Gravis, myositis, and CIDP, ...
In the United States, there are approximately 250,000 people diagnosed with primary immunodeficiency disease (PIDD), and thousands more go undetected. PIDD occurs in patients born with an immune ...
Data presented at biennial ESID meeting reveal pharmacoeconomic benefits of switching from IVIG to SCIg in primary immunodeficiency FLORENCE, Italy, Oct. 4, 2012 /CNW/ - Analysis using a new economic ...
NEW YORK (Reuters Health) - Intravenous immunoglobulin (IVIg) may offer some relief for patients with sensorimotor neuropathy or nonataxic sensory neuropathy associated with primary Sjögren's syndrome ...
Connie Sullivan, president and CEO of the National Home Infusion Association (NHIA), discusses why at-home infusion is beneficial to patients and why so many patients reported feeling satisfied with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback